Stocktoria
ASHLAND INC. ASH
ASHLAND INC. (ASH) earns a Piotroski F-score of 5/9 (mixed financial health), with an Altman Z″ in the grey zone. It pays a dividend yielding 2.60% (safety: n/a).
Quality score trend · recomputed for each fiscal year
Each year's score is computed from that year's filing — a rising Piotroski F or Altman Z″ means improving financial health, a fall is worth a look.
Analyst price target
Recent analyst actions
| Date | Firm | Rating |
|---|---|---|
| 2026-06-10 | UBS | Buy (main) |
| 2026-05-06 | Seaport Global | Buy (up) |
| 2026-04-30 | JP Morgan | Overweight (main) |
| 2026-04-30 | Wells Fargo | Equal-Weight (main) |
| 2026-03-23 | Argus Research | Buy (main) |
| 2026-02-18 | Evercore ISI Group | In-Line (main) |
Wall Street analyst consensus — a sentiment gauge, not our scoring.
How it ranks in Wholesale Trade · percentile among 112 companies
Percentile vs other Wholesale Trade companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.
Piotroski F breakdown · 5/9 tests passed
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″ components · grey zone
| Component | Value |
|---|---|
| Working capital / assets | 0.17 |
| Retained earnings / assets | 0.498 |
| EBIT / assets | -0.168 |
| Equity / liabilities | 0.703 |
Sector peers · similar-size Wholesale Trade companies compare side by side →
| Ticker | Company | Piotroski F | Altman Z″ | P / E | Revenue growth |
|---|---|---|---|---|---|
| ASH | ASHLAND INC. | 5/9 | 2.35 | — | -13.7% |
| HWKN | HAWKINS INC | 4/9 | 4.56 | 41.4 | +11.2% |
| MCK | MCKESSON CORP | 6/9 | 0.58 | 18.8 | +12.4% |
| CAH | CARDINAL HEALTH INC | 6/9 | -0.03 | 32.5 | +14.2% |
| SYY | SYSCO CORP | 5/9 | — | 21.7 | +3.2% |
| PFGC | Performance Food Group Co | 4/9 | 1.92 | 48.3 | +7.2% |
| SNX | TD SYNNEX CORP | 6/9 | 1.78 | 25.9 | +6.9% |
All Wholesale Trade companies →
About ASHLAND INC.
Ashland Inc. provides additives and specialty ingredients in the North and Latin America, Europe, Asia Pacific, and internationally. It operates through Life Sciences, Personal Care, Specialty Additives, and Intermediates segments. The Life Sciences segment offers pharmaceutical solutions, including controlled release polymers, disintegrants, tablet coatings, thickeners, solubilizers, and tablet binders; and nutrition solutions, such as thickeners, stabilizers, emulsifiers, and additives; agricultural chemicals; diagnostic films; and fine chemicals. Its Personal Care segment provides a range of natural, nature-derived, biodegradable, and performance ingredients; solutions for toothpastes, mouth washes and rinses, denture cleaning, and care for teeth; and household supplies nature-derived rheology ingredients, biodegradable surface wetting agents, performance encapsulates, and specialty polymers. The Specialty Additives segment offers rheology modifiers, foam control agents, surfactants and wetting agents, pH neutralizers, advanced ceramics used in catalytic converters, environmental filters, ingredients for the manufacturing of ceramic capacitors, plasma display panels and solar cells, ingredients for textile printing, thermoplastic metals, and alloys for welding. Its Intermediates segment produces 1,4 butanediol and related derivatives, including n-methylpyrrolidone. It offers its products to customers in a range of consumer and industrial markets, such as architectural coatings, construction, energy, food and beverage, personal care, and pharmaceutical. The company was formerly known as Ashland Global Holdings Inc. and changed its name to Ashland Inc. in August 2022. Ashland Inc. was founded in 1924 and is headquartered in Wilmington, Delaware.
FAQ
Is ASH financially healthy?
ASHLAND INC.'s Piotroski F-score is 5/9 (8–9 is excellent, 0–3 weak), and its Altman Z″ distress score is in the grey zone.
Does ASH pay a dividend, and is it safe?
Yes. ASHLAND INC. pays a dividend yielding about 2.60% with a None payout ratio, rated “n/a” for safety.
Is ASH overvalued or undervalued?
ASHLAND INC. trades at about 22.2× trailing earnings — near its 10-year norm (10-year range 6.4×–6798.0×, median 23.2×). Stocktoria reports the data, not buy/sell advice.
What is the analyst price target for ASH?
The average Wall-Street price target for ASHLAND INC. is $68.82, about 7.9% below the recent price, from 11 analysts (consensus: buy).
Is ASH a good stock to buy?
Stocktoria doesn't give buy or sell advice, but here is the data on ASHLAND INC.: a Piotroski F-score of 5/9, an Altman Z″ in the grey zone, a dividend yield of 2.60%. Weigh these quality and valuation signals against your own goals.
Computed from company filings · US · as of 2025-09-30. Facts plus Stocktoria's own computed scores — not investment advice.